ARK Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Sell |
|
|||||
|
2025
Q1 | $12.8M | Buy |
|
|||||
|
2024
Q4 | $10.2M | Sell |
|
|||||
|
2024
Q3 | $23.8M | Sell |
|
|||||
|
2024
Q2 | $35.4M | Sell |
|
|||||
|
2024
Q1 | $37.7M | Sell |
|
|||||
|
2023
Q4 | $50.5M | Buy |
|
|||||
|
2023
Q3 | $40.1M | Sell |
|
|||||
|
2023
Q2 | $40.7M | Sell |
|
|||||
|
2023
Q1 | $38M | Sell |
|
|||||
|
2022
Q4 | $35.3M | Sell |
|
|||||
|
2022
Q3 | $45.6M | Sell |
|
|||||
|
2022
Q2 | $98.2M | Sell |
|
|||||
|
2022
Q1 | $110M | Sell |
|
|||||
|
2021
Q4 | $204M | Sell |
|
|||||
|
2021
Q3 | $310M | Sell |
|
|||||
|
2021
Q2 | $358M | Buy |
|
|||||
|
2021
Q1 | $369M | Buy |
|
|||||
|
2020
Q4 | $193M | Buy |
|
|||||
|
2020
Q3 | $26.5M | Buy |
|